Immutep IMMP
NASDAQ IMMP
$3.20 +0.06 (+1.91%)
At close: Oct 23, 2026 · 4:00 PM EDT

Immutep (IMMP) Income from Non-Controlling Interests (2011)

Updated

Immutep (IMMP) recorded Income from Non-Controlling Interests of -$23.73 trillion in the year ended Jun 30, 2022, compared with -$23.47 trillion a year earlier.

Analysis

Immutep (IMMP) Income from Non-Controlling Interests (2011) Analysis & Trends

Starting with the year ended Jun 30, 2010, Immutep's Income from Non-Controlling Interests history includes 9 years.

  • The figure for the year ended Jun 30, 2022 is the lowest annual Income from Non-Controlling Interests in data going back to the year ended Jun 30, 2010.
  • Per Business Quant data, IMMP's Income from Non-Controlling Interests was -$23.47 trillion in the year ended Jun 30, 2021, -$8.76 trillion in the year ended Jun 30, 2020, -$12.46 trillion in the year ended Jun 30, 2019 and -$8.85 trillion in the year ended Jun 30, 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 3.00 Mn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -2.00 Mn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -7.00 Mn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 1.00 Mn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 10.00 Mn
10 Immutep 23.22 Mn -187.80 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2011 74.32
API Access

Immutep Income from Non-Controlling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=IMMP&period=max&api_key=YOUR_API_KEY